Health Care & Life Sciences » Pharmaceuticals | Kunming Longjin Pharmaceutical Co. Ltd.

Kunming Longjin Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
-
63,573.00
61,762.80
91,001.00
35,159.50
13,827.70
Depreciation, Depletion & Amortization
-
22,303.20
22,493.20
23,117.80
23,145.90
23,928.20
Other Funds
60,000.00
-
302,137.50
-
-
5,511.70
Funds from Operations
106,688.60
86,020.50
84,309.80
89,418.80
54,982.70
44,845.40
Changes in Working Capital
-
17,160.60
12,980.20
21,283.40
13,098.10
5,276.70
Net Operating Cash Flow
106,688.60
68,859.90
71,329.60
110,702.10
68,080.80
39,568.70
Capital Expenditures
59,572.30
18,472.90
23,934.40
23,555.20
17,539.10
Sale of Fixed Assets & Businesses
110.50
-
370.00
540.90
-
Purchase/Sale of Investments
-
-
170,000.00
211,500.00
25,000.00
Net Investing Cash Flow
51,071.80
13,472.90
186,564.40
234,514.30
7,460.90
Cash Dividends Paid - Total
-
80,000.00
50,062.50
20,025.00
60,075.00
Issuance/Reduction of Debt, Net
-
30,000.00
30,000.00
-
-
Net Financing Cash Flow
60,000.00
50,000.00
222,075.00
20,025.00
60,075.00
Net Change in Cash
4,383.20
5,387.00
106,840.20
143,837.20
15,466.70
Free Cash Flow
47,116.30
50,387.00
47,395.20
87,147.00
50,541.70
Deferred Taxes & Investment Tax Credit
-
182.70
158.00
1,563.50
8,133.00
1,577.70
Other Sources
8,390.00
5,000.00
7,000.00
-
-

About Kunming Longjin Pharmaceutical Co.

View Profile
Address
No. 789 Lanmao Road
Kunming Yunnan 650503
China
Employees -
Website http://www.longjin.com.cn
Updated 07/08/2019
Kunming Longjin Pharmaceutical Co., Ltd. engages in the development, manufacture, and sale of natural herbal and chemical freeze-dried medicines. Its products include cardiovascular, digestive system, and immune system drugs, and emergency medicine as well as vitamins, minerals, and internal nutrition therapy products. The company was founded on September 16, 1996 and is headquartered in Kunming, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.